301 related articles for article (PubMed ID: 6438857)
1. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
Soloway MS
Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
[TBL] [Abstract][Full Text] [Related]
2. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
3. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Hofmann W; Langkopf B
Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
[No Abstract] [Full Text] [Related]
4. [Progress in the internist treatment of bladder tumors].
Baumgartner G
Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
[TBL] [Abstract][Full Text] [Related]
5. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
Soloway MS
Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
[No Abstract] [Full Text] [Related]
6. [Intravesical chemotherapy in superficial tumors of the bladder].
Schulman CC
Arch Esp Urol; 1983; 36(1):32-40. PubMed ID: 6409013
[No Abstract] [Full Text] [Related]
7. Intravesical chemotherapy in the management of superficial bladder tumors.
Schulman CC
Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
[No Abstract] [Full Text] [Related]
8. Intravesical therapy for bladder cancer.
Soloway MS
Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
[TBL] [Abstract][Full Text] [Related]
9. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapy of bladder cancer.
Salem PA
Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726
[No Abstract] [Full Text] [Related]
11. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
12. Intravesical chemotherapy.
Prout GR
Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
[No Abstract] [Full Text] [Related]
13. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Kurth KH; Bouffioux C; Sylvester R; de Pauw M
Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
[No Abstract] [Full Text] [Related]
14. Intravesical chemotherapy. Treatment selection, techniques, and results.
Richie JP
Urol Clin North Am; 1992 Aug; 19(3):521-7. PubMed ID: 1636236
[TBL] [Abstract][Full Text] [Related]
15. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
Huben RP
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
[TBL] [Abstract][Full Text] [Related]
16. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
Koontz WW; Heney NM; Soloway MS; Kluskens L; Hazra TA; Trump DL; Barton B
Urology; 1985 Oct; 26(4 Suppl):30-1. PubMed ID: 3931326
[TBL] [Abstract][Full Text] [Related]
18. [Intravesical chemotherapy for superficial bladder tumors].
Ohmori H
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
[TBL] [Abstract][Full Text] [Related]
19. Intravesical chemotherapy--frequency of instillation.
Smith PH
Prog Clin Biol Res; 1985; 185B():57-68. PubMed ID: 3929271
[No Abstract] [Full Text] [Related]
20. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
